Issue Cover

Manufacturing

Manufaturing and production news from the pharmaceutical industry

Articles

BioNTech’s Rwanda vaccine manufacturing site achieves milestone
BioNTech’s Rwanda vaccine manufacturing site achieves milestone

BioNTech has announced that it has reached the next milestone in the establishment of its mRNA vaccine manufacturing capacities in Africa, with the introduction of the new site in Kigali, Rwanda.

7 February 2024Manufacturing
Novo Nordisk invests 42bn Danish kroner in manufacturing facilities in Kalundborg, Denmark
Novo Nordisk invests 42bn Danish kroner in manufacturing facilities in Kalundborg, Denmark

Novo Nordisk has announced plans to invest over 42bn Danish kroner to expand its existing manufacturing facilities in Kalundbord, Denmark, for production of the company’s current and future product portfolio within serious chronic diseases.

24 November 2023Manufacturing
GSK’s Ventolin low carbon inhaler to progress to phase 3 trials in 2024
GSK’s Ventolin low carbon inhaler to progress to phase 3 trials in 2024

GSK has announced that in 2024 it intends to start phase 3 trials of a low carbon version of its metered-dose inhaler ventolin (salbutamol) using a next-generation propellant.

24 November 2023Manufacturing
Fresenius Kabi’s manufacturing site to be acquired by Prange Group and Adragos Pharma
Fresenius Kabi’s manufacturing site to be acquired by Prange Group and Adragos Pharma

Prange Group and Adragos Pharma have announced the signing of definitive agreements with Fresenius Kabi for their acquisition of its leading sterile pharmaceutical production site in Halden, Norway.

24 November 2023Manufacturing
Merck invests €35m in biosafety testing in Scotland
Merck invests €35m in biosafety testing in Scotland

Merck has announced that it has invested €35m in biosafety testing at its sites in Glasgow and Stirling, both Scotland.

2 July 2023Manufacturing
Medtronic’s extravascular defibrillator receives CE mark
Medtronic’s extravascular defibrillator receives CE mark

Medtronic has received the CE mark for its extravascular defibrillator. The Aurora EV-ICD MRI SureScan and epsila EV MRI SureScan defibrillation lead treat abnormally fast heart rhythms, which can lead to sudden cardiac arrest.

2 April 2023Manufacturing
Moderna chooses Oxfordshire for new UK facility
Moderna chooses Oxfordshire for new UK facility

US biotech firm Moderna has chosen Harwell Science Campus in Oxfordshire for its new UK R&D facility. The campus is already home to more than 70 organisations and sits within the UK’s ‘golden triangle’, an area rich in life sciences facilities, between Oxford, Cambridge and London.

2 April 2023Manufacturing
REGENXBIO presents interim phase 2 data from drug developed on NAVXpress platform
REGENXBIO presents interim phase 2 data from drug developed on NAVXpress platform

REGENXBIO, a clinical-stage biotech company, has announced positive phase 2 data for its drug rxg-314, which was developed by the company’s NAVXpress bioreactor platform process.

2 April 2023Manufacturing
Johnson & Johnson Scale Back COVID-19 Vaccination Production
Johnson & Johnson Scale Back COVID-19 Vaccination Production

J&J has begun scaling back its COVID-19 vaccine producation due to the falling demand for the jabs

6 March 2023Manufacturing
Eli Lilly Plans To Invest $450m At Production Site In Research Triangle Park
Eli Lilly Plans To Invest $450m At Production Site In Research Triangle Park

Eli Lilly has announced plans to invest $450m in manufacturing facilities at Research Triangle Park in North Carolina, US

6 March 2023Manufacturing
Daiichi Sankyo To Build Japan’s First Factory For mRNA COVID-19 Vaccines
Daiichi Sankyo To Build Japan’s First Factory For mRNA COVID-19 Vaccines

Daiichi Sankyo shares plans to build its first mRNA COVID-19 vaccine factory in Japan

6 March 2023Manufacturing
Sarepta Therapeutics And Catalent Sign Manufacturing Deal For Dmd Gene Therapy Approval
Sarepta Therapeutics And Catalent Sign Manufacturing Deal For Dmd Gene Therapy Approval

Sarepta Therapeutics is a company focused on gene therapy, RNA and gene editing, engineering precision genetic medication for rare diseases. It has announced the signing of a commercial supply agreement with Catalent that will allow the company to manufacture delandistrogene moxeparvovec (SRP-9001), Sarepta’s most advanced gene therapy candidate for the treatment of Duchenne muscular dystrophy (DMD).

1 February 2023Manufacturing